British American Tobacco Reports Strong 2025 Profit Growth, Advances New Categories, and Expands Share Buyback

summarizeSummary

British American Tobacco reported a 265% surge in reported operating profit for 2025, driven by a Canadian litigation settlement adjustment, alongside a 2.0% dividend increase and an expanded share buy-back program.

check_boxKey Events

• Strong Reported Profit Growth

  Reported profit from operations surged 265% to £9,997 million in 2025, primarily due to a net credit from the Canadian litigation settlement. Adjusted diluted EPS (at constant rates) increased by 0.7%.

• Canadian Litigation Settlement Update

  The company finalized terms for the Canadian litigation settlement, resulting in a £708 million credit to the provision and an upfront payment of £2.56 billion in the second half of 2025. Annual payments are expected for at least 40 years.

• Enhanced Shareholder Returns

  British American Tobacco increased its dividend by 2.0% and extended its share buy-back program, with an additional £1.3 billion planned for 2026, following £1.1 billion purchased in 2025.

• New Categories Drive Revenue Growth

  Revenue from New Categories grew 5.5% (7.0% at constant currency) to £3,621 million, significantly boosted by a 47.4% increase in Modern Oral products, despite a decline in Vapour revenue.

auto_awesomeAnalysis

This 20-F annual report provides comprehensive, audited financial results for 2025, detailing significant operational and strategic developments. The substantial increase in reported profit from operations, largely driven by a favorable adjustment to the Canadian litigation provision, is a key highlight. The company's continued commitment to shareholder returns is evident through the 2.0% dividend increase and the extension of its share buy-back program with an additional £1.3 billion planned for 2026. Strategic shifts, including the divestment of a further stake in ITC and the exit from Cuba, aim to streamline the portfolio. While New Categories show promising growth, challenges from illicit products and regulatory uncertainties persist. Investors should note the long-term financial implications of the Canadian litigation settlement, despite the positive accounting impact this year.